Acadia Pharmaceuticals (ACAD) Change in Inventory (2016 - 2026)

Acadia Pharmaceuticals' Change in Inventory history runs 11 years deep, the most recent figure standing at -$78000.0 for Q1 2026.

• In Q1 2026, Change in Inventory fell 100.75% year-over-year to -$78000.0; the TTM figure through Mar 2026 stood at $7.7 million (down 82.32% YoY), while the FY2025 annual figure was $18.2 million, down 63.28% from the prior year.
• Change in Inventory was -$78000.0 for Q1 2026 at Acadia Pharmaceuticals, down from $4.9 million in the prior quarter.
• In the past five years, Change in Inventory ranged from a high of $27.1 million in Q2 2024 to a low of -$1.2 million in Q3 2025.
• Historically, Change in Inventory has averaged $5.5 million across 5 years, with a median of $3.0 million in 2023.
• The sharpest annual moves came in 2022 and 2023: Change in Inventory plunged 269.31% in 2022, then soared 4960.32% in 2023.
• A 5-year view of Change in Inventory shows it stood at -$310000.0 in 2022, then jumped by 4960.32% to $15.1 million in 2023, then slumped by 70.64% to $4.4 million in 2024, then increased by 10.58% to $4.9 million in 2025, then tumbled by 101.59% to -$78000.0 in 2026.
• The last three Change in Inventory figures came in at -$78000.0 (Q1 2026), $4.9 million (Q4 2025), and -$1.2 million (Q3 2025), per Business Quant data.